Your browser doesn't support javascript.
loading
Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study.
Brooks, W Abdullah; Chang, Lee-Jah; Sheng, Xiaohua; Hopfer, Robert.
  • Brooks WA; International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka, Bangladesh; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Chang LJ; Sanofi Pasteur, Swiftwater, PA, USA.
  • Sheng X; Sanofi Pasteur, Swiftwater, PA, USA.
  • Hopfer R; Sanofi Pasteur, Swiftwater, PA, USA. Electronic address: robert.hopfer@sanofipasteur.com.
Vaccine ; 33(36): 4610-7, 2015 Aug 26.
Article en En | MEDLINE | ID: mdl-26143615

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Streptococcus pneumoniae / Proteínas Bacterianas / Vacunas Neumococicas / Antígenos Bacterianos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Infant / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Streptococcus pneumoniae / Proteínas Bacterianas / Vacunas Neumococicas / Antígenos Bacterianos Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans / Infant / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article